Sanofi SA (NASDAQ:SNY)

46.55
Delayed Data
As of Mar 05
 +0.65 / +1.42%
Today’s Change
37.62
Today|||52-Week Range
55.00
-4.20%
Year-to-Date
Where Will Vaxart Be in 1 Year?
Mar 06 / MotleyFool.com - Paid Partner Content
Mario Gabelli's Gabelli Value 25 Fund 2020 Annual Shareholder Letter
Mar 01 / GuruFocus News - Paid Partner Content
Sanofi's (SNY) Dupixent sBLA for Asthma Gets FDA Acceptance
Mar 05 / Zacks.com - Paid Partner Content
Magenta Is Ready to Paint Your Portfolio Green
Feb 27 / MotleyFool.com - Paid Partner Content
Will Sanofi and GlaxoSmithKline Be Too Late to the Party With Their COVID Vaccine?
Mar 05 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: SNY/GSK & PFE COVID-19 Vaccine Update, MRK's Pandion Buyout
Feb 26 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: REGN, VIR's COVID-19 Updates, KMPH's Drug Approval & More
Mar 04 / Zacks.com - Paid Partner Content
BioMarin (BMRN) Q4 Earnings Beat, 2021 Sales View Dull
Feb 26 / Zacks.com - Paid Partner Content
Amicus' (FOLD) Q4 Earnings Miss Estimates, Sales Beat on Galafold
Mar 02 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Regulatory Updates From REGN, INCY, & Other Updates
Feb 24 / Zacks.com - Paid Partner Content
Novavax (NVAX) Loss Widens in Q4, Revenues Top Estimates
Mar 02 / Zacks.com - Paid Partner Content
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?
Feb 23 / Zacks.com - Paid Partner Content
Denali's (DNLI) Q4 Earnings & Revenues Beat on Biogen Deal
Mar 01 / Zacks.com - Paid Partner Content